Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: opty / Re: Just what does PTSC have to tell shareholders?... Stillpoint

< I agree with you and the rest of the group here, it's better to let the current three BODges continue to manage the company so that we can maintain the impressive 8 cent share price.>

I never said the above nor have I even hinted of it. Your characterization of me is wrong, but not unexpected.

As to your suggestion. Unfortunately it might take quite a bit more than 51% of the shareholders to obtain 51% of the outstanding stock. But even if you did find that kind of support for some specific effort, you may still need to fight the company. One individual owing 51% of the shares is the company. So while it may sound a bit like the control I spoke of, it certainly is not the same. IMO.

Opty


Jul 06, 2011 05:32PM
Share
New Message
Please login to post a reply